Fractional Laser as Treatment Option for Various Pigment Disorders — fractional-2  

Pigmentation Disorder Clinical Trial

Official title: Ablative Fractional Laser Therapy as Treatment for Becker's Nevus; a Pilot Study

Status Completed

Clinical Trial Summary

The purpose of this study is to determine whether the use of ablative fractional laser is effective in the treatment of Becker's nevus.

Clinical Trial Description

Becker's nevus (BN) is an uncommon pigment disorder of the epidermis characterized by increased pigmentation, a slightly elevated, verrucous surface of the affected skin and sometimes hyperpigmentation. No effective treatment is available. Several laser modalities have been applied in the treatment of Becker's nevus in uncontrolled studies with varying results. Recently, fractional laser therapy was suggested as treatment option for Becker's nevus. In fractional laser therapy, microscopic columns of skin are coagulated or ablated, leaving the surrounding tissue intact, which enhances healing of the treated skin. In this study, the efficacy and safety of ablative fractional laser therapy was assessed in the treatment of Becker's nevus. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Pigmentation Disorder
• Pigmentation Disorders

• NCT number: NCT01083498
• Study type: Interventional
• Source: Netherlands Institute for Pigment Disorders
• Status: Completed
• Phase: Phase 2
• Start date: March 2009
• Completion date: January 2010